EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Succinylation of 14–3–3 theta by CPT1A promotes survival and paclitaxel resistance in nasal type extranodal natural killer/T-cell lymphoma

Xiao Cui, Chengcheng Cao, Xinyang Li, Biyan Lin, Aihui Yan, Ying Yang

Translational Oncology · 2024-08 · 46 · 102006

DOI: 10.1016/j.tranon.2024.102006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Oncology, 2024-08. Verfasst von Xiao Cui und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, The First Hospital of China Medical University, Shenyang 110003, China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

14–3–3thetaApoptosisCarnitine palmitoyltrasferase 1AExtranodal natural killer/T-cell lymphomaProliferationSuccinylation

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, The First Hospital of China Medical University, Shenyang 110003, China.
  • Department of Pathology, Shengjing Hospital of China Medical University, Shenyang 110004, China.
  • Department of Hematology, Shengjing Hospital of China Medical University, Shenyang 110022, China.
  • Department of Otorhinolaryngology, The First Hospital of China Medical University, Shenyang 110003, China. Electronic address: yanmenxueshu@163.com.
  • Department of Hematology, Shengjing Hospital of China Medical University, Shenyang 110022, China. Electronic address: yangy5@sj-hospital.org.

Zitieren

APA

Cui, X., Cao, C., Li, X., Lin, B., Yan, A., & Yang, Y. (2024). Succinylation of 14–3–3 theta by CPT1A promotes survival and paclitaxel resistance in nasal type extranodal natural killer/T-cell lymphoma. Translational Oncology, 46, 102006. https://doi.org/10.1016/j.tranon.2024.102006

Vancouver

Cui X, Cao C, Li X, Lin B, Yan A, Yang Y. Succinylation of 14–3–3 theta by CPT1A promotes survival and paclitaxel resistance in nasal type extranodal natural killer/T-cell lymphoma. Translational Oncology. 2024;46:102006. doi:10.1016/j.tranon.2024.102006

BibTeX
@article{Cui2024,
  author = {Cui, Xiao and Cao, Chengcheng and Li, Xinyang and Lin, Biyan and Yan, Aihui and Yang, Ying},
  title = {Succinylation of 14–3–3 theta by CPT1A promotes survival and paclitaxel resistance in nasal type extranodal natural killer/T-cell lymphoma},
  journal = {Translational Oncology},
  year = {2024},
  volume = {46},
  pages = {102006},
  doi = {10.1016/j.tranon.2024.102006}
}
Kostenlos starten →